Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Amarantus Bioscience Holdi AMBS
Posted On: 01/04/2015 3:46:04 PM
Post# of 30066
Avatar
Posted By: redspeed
Not sure if anyone remembers this one from July. Turns out it's much easier to produce a PR than to bring a test to market.

New Alzheimer’s test may help future clinical trials

http://www.nhs.uk/news/2014/07July/Pages/Bloo...-toss.aspx


NHS Choices has dampened enthusiasm over a report in medical journal Alzheimer’s & Dementia of a new test for Alzheimer’s disease, which purports to be ‘87% accurate’ in predicting the start of dementia.

"However, in a response on its website, NHS Choices says: “While the test accuracy rate of 87% sounds impressive, it may be a large overestimate of what would happen in reality. ”

http://www.pharmafile.com/news/189828/alzheim...ay-reports













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site